Owned by the Association for International Promotion & Study in Tumors (APSIT)
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) ranks the most common primary liver malignancy and the third leading cause of tumor-related mortality worldwide. Unfortunately, despite advances in HCC treatment, less than 40% o...
Citation: Journal of Experimental & Clinical Cancer Research 2019 38:396